The National Adrenal Diseases Foundation informs, educates, and supports those with adrenal disease and their families to improve their quality of life.
We Moved – Kind of
We updated our contact information to make correspondences more efficient:
National Adrenal Diseases Foundation
P.O. Box 566
Lake Zurich, IL 60047
(847) 726-9010 Phone
(847) 438-6715 Fax
Clinical Trial – Adults With Classic Congenital Adrenal Hyperplasia (CAH)
New! Overview of Stress Dosing
Adrenal Insufficiency Patient Guide to Management of Illness and Stress-Related Medical Events
Clinical Trial – Circadian Function and Cardio-metabolic Risk in Adrenal Insufficiency
Patients with primary or secondary Adrenal Insufficiency age 18 and older may apply and that the study is done by University of Chicago.
Please follow this link for more information: Circadian Function and Cardio-metabolic Risk in Adrenal Insufficiency
NEW! Survey for Medical Community on Adrenal Insufficiency
NADF with support from Opinion Health, a healthcare research agency based in London, UK, conducted a National Survey on adrenal Insufficiency (AI).
Diagnosis and Treatment of Primary Adrenal Insufficiency Guideline
This clinical practice guideline addresses the diagnosis and treatment of primary adrenal insufficiency.
Download the guide: An Endocrine Society Clinical Practice Guideline.
NADF joins the Autoimmune Research Network (ARNet)
If you have Addison’s disease caused by autoimmunity, please complete the ARNet survey at https://www4.gvtsecure.com/arnet/genfunc.exe?NADF. This will only take about 15 minutes and could make a huge difference in future research.
NADF is encouraging you to fill out the information as we hope this can lead to a better understanding of Addison’s, including research on its causes, potential treatments, and perhaps even a cure. If NADF learns you might be eligible candidate for a study, we will contact you with information about the research.
NADF joined the Autoimmune Research Network (ARNet) in hopes that it will boost autoimmunity research, including Addison’s disease.
Clinical trial for adrenal patients